These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2900259)

  • 1. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
    Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
    J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
    Kirshenbaum JM; Kloner RA; Antman EM; Braunwald E
    Circulation; 1985 Oct; 72(4):873-80. PubMed ID: 2863013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of esmolol on patients with left ventricular dysfunction.
    Iskandrian AS; Bemis CE; Hakki AH; Panidis I; Heo J; Toole JG; Hua TA; Allin D; Kane-Marsch S
    J Am Coll Cardiol; 1986 Jul; 8(1):225-31. PubMed ID: 2872244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
    Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
    Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
    Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
    Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
    Askenazi J; MacCosbe PE; Hoff J; Turlapaty P; Hua TA; Laddu A
    J Clin Pharmacol; 1987 Aug; 27(8):567-73. PubMed ID: 2888793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
    Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
    Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension.
    Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
    Am J Cardiol; 1987 Apr; 59(8):887-91. PubMed ID: 2881481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of esmolol during myocardial revascularization.
    Girard D; Shulman BJ; Thys DM; Mindich BP; Mikula SK; Kaplan JA
    Anesthesiology; 1986 Aug; 65(2):157-64. PubMed ID: 3526984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of esmolol for unstable angina pectoris.
    Wallis DE; Pope C; Littman WJ; Scanlon PJ
    Am J Cardiol; 1988 Nov; 62(16):1033-7. PubMed ID: 2903659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina.
    Barth C; Ojile M; Pearson AC; Labovitz AJ
    Am Heart J; 1991 Mar; 121(3 Pt 1):782-8. PubMed ID: 1672051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
    Berry JM; Michalsen A; Nagle V; Bull JM
    Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of esmolol in chronically beta-blocked patients undergoing aortocoronary bypass surgery.
    de Bruijn NP; Croughwell N; Reves JG
    Anesth Analg; 1987 Feb; 66(2):137-41. PubMed ID: 2880530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children.
    Cuneo BF; Zales VR; Blahunka PC; Benson DW
    Pediatr Cardiol; 1994; 15(6):296-301. PubMed ID: 7838803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of myocardial ischemia during coronary occlusion by ultrashort-acting beta adrenergic blockade.
    Labovitz AJ; Barth C; Castello R; Ojile M; Kern MJ
    Am Heart J; 1991 May; 121(5):1347-52. PubMed ID: 1673282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.